Travere Therapeutics Inc (TVTX) — Net Asset Quality Index
Travere Therapeutics Inc (TVTX) has a Net Asset Quality Index of 17.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $555.19 Million minus total liabilities of $456.46 Million yields net assets of $98.73 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Travere Therapeutics Inc for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Travere Therapeutics Inc Net Asset Quality Index Over Time (2010–2025)
This chart shows how Travere Therapeutics Inc's Net Asset Quality Index has evolved across 16 annual periods from 2010 to 2025. As of March 2026, the index stands at 17.8%, representing net assets of $98.73 Million against total assets of $555.19 Million USD. For live market cap and overall valuation, see market value of Travere Therapeutics Inc.
Annual Net Asset Quality Index for Travere Therapeutics Inc (2010–2025)
The table below presents the year-by-year Net Asset Quality Index for Travere Therapeutics Inc from 2010 to 2025, covering 16 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check TVTX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 19.0% | $114.83 Million | $605.19 Million | $490.36 Million | ▲ +9.0 pp |
| 2024 | 9.9% | $59.08 Million | $594.12 Million | $535.05 Million | ▼ -15.5 pp |
| 2023 | 25.5% | $200.81 Million | $788.91 Million | $588.10 Million | ▲ +19.1 pp |
| 2022 | 6.4% | $42.85 Million | $672.59 Million | $629.73 Million | ▼ -32.5 pp |
| 2021 | 38.9% | $302.11 Million | $776.63 Million | $474.52 Million | ▲ +4.1 pp |
| 2020 | 34.8% | $211.21 Million | $607.44 Million | $396.23 Million | ▼ -1.8 pp |
| 2019 | 36.6% | $221.20 Million | $604.80 Million | $383.60 Million | ▼ -8.3 pp |
| 2018 | 44.9% | $318.25 Million | $709.16 Million | $390.91 Million | ▼ -11.5 pp |
| 2017 | 56.3% | $293.13 Million | $520.35 Million | $227.21 Million | ▼ -2.3 pp |
| 2016 | 58.6% | $307.77 Million | $525.28 Million | $217.51 Million | ▲ +0.0 pp |
| 2015 | 58.5% | $299.97 Million | $512.40 Million | $212.43 Million | ▲ +86.0 pp |
| 2014 | -27.5% | $-37.25 Million | $135.47 Million | $172.72 Million | ▲ +61.8 pp |
| 2013 | -89.3% | $-18.31 Million | $20.50 Million | $38.81 Million | ▲ +53.2 pp |
| 2012 | -142.5% | $-3.41 Million | $2.39 Million | $5.80 Million | ▲ +1471.2 pp |
| 2011 | -1613.7% | $-63.08K | $3.91K | $66.99K | ▼ -91.4 pp |
| 2010 | -1522.4% | $-60.26K | $3.96K | $64.21K | — |